Do kids get long COVID? Look for these unique signs and symptoms. MedTwitter
, looking at long COVID in kids, is instructive. It's how this research needs to be done. The study appears inhave presented this data. They didn't, but I think it's important to understand how we can get such drastically different estimates of long COVID in kids or adults.
Of the 59,893 kids in the study who tested positive for COVID , 41.9% — almost half — had a symptom, sign, or medication suggestive of long COVID in the 28-180 days after that positive COVID test. The headlines write themselves.But this is not, thankfully, how the study was conducted. The authors recognize that with so many potential manifestations of long COVID , kidsThe authors used a logical one: kids tested for COVID whose test was negative.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Myocarditis Risk Higher After COVID-19 Infection than After COVID-19 VaccinationThe risk of myocarditis is substantially higher in the 4 weeks after COVID-19 infection than after a first dose of a COVID-19 vaccine, say researchers of new study. CardioTwitter
Read more »
Long Covid: Mum puts hopes in experimental treatmentKate Stott will travel from Aberdeen to Germany to get experimental treatment for blood microclots.
Read more »
Philippine kids back in school after 2 years lost to COVID-19Millions of students in face masks streamed back to primary and secondary schools across the Philippines for their first in-person classes in two years
Read more »
Pfizer asks FDA to authorize updated COVID vaccine adding protection from Omicron variantsThe FDA ordered vaccine makers to tweak their shots to target BA.4 and BA.5. Pfizer and its partner BioNTech aim to offer updated boosters to people 12 and older, and shots could begin within weeks if the FDA quickly clears the modified vaccine.
Read more »
Pfizer-BioNTech submits new COVID vaccine booster targeting BA.5 to the FDA for authorizationPfizer and German partner BioNTech have submitted their new COVID-19 booster – that targets the omicron subvariant BA.5 – to the FDA for emergency use authorization.
Read more »